Black Cohosh for Hot Flashes

Verdict: Does not relieve hot flashes; liver-safety concerns

The best-quality clinical trials show that black cohosh does not reduce hot flashes any better than a placebo, and regulators have flagged a rare but serious risk of liver injury. It is not a reliable treatment for menopausal hot flashes.

D 🔴 D Counter-Evidence Counter-Evidence

🔬Why this grade7-layer evidence engine

The grade is driven by the highest-quality evidence on hot flashes specifically. The 2012 Cochrane review (PMID 22972105, n=2027) found no difference from placebo in hot-flash frequency (a mean difference of just 0.07 flushes per day, p=0.79) and judged the evidence insufficient. The NIH-funded NCCTG Phase III trial (PMID 16782922, n=132) was even less encouraging: black cohosh was numerically worse than placebo (20% vs 27% reduction in hot-flash score, p=0.53).

A 2023 pooled meta-analysis (PMID 37192826) did report a small statistically significant benefit (Hedges' g = 0.315), but that signal came mainly from smaller, heterogeneous, and partly industry-sponsored trials of varying extract types and doses. It does not outweigh the consistent null results from the larger, rigorously designed placebo-controlled studies, especially given that placebo alone often cuts hot flashes by roughly 30%.

Mainstream sources reinforce this caution. The UK NHS states the supposed benefit is 'not supported by scientific evidence,' and Mayo Clinic notes that efficacy studies have had 'mixed results' alongside a rare possible link to liver damage. Harvard Health and menopause-specialty guidance advise against relying on it. Multiple regulators (UK MHRA, EU, and others) mandate liver-injury warnings, making the benefit-to-risk balance unfavorable for this non-life-threatening symptom.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.39
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
D · Counter-Evidence
Confidence
82%
Highly consistent evidence
Evidence level
E1
Cochrane high-quality SR/MA

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.26
L11 AI re-checkIndependent read
0.30
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.393
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 1 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (7)L2 · primary research & systematic reviews

Black cohosh extracts in women with menopausal symptoms: an updated pairwise meta-analysis
PMID: 37192826 2023 統合分析 n = 2,310
Finding: Black cohosh significantly reduced hot flashes (Hedges' g = 0.315, p = 0.003) and overall menopausal symptoms (Hedges' g = 0.575, p < 0.001); no benefit for anxiety or depression.
Mixed funding Effect size: Hedges' g = 0.315 (hot flashes); Hedges' g = 0.575 (overall symptoms)
View on PubMed
Black cohosh (Cimicifuga spp.) for menopausal symptoms (Cochrane review)
PMID: 22972105 2012 系統性回顧 n = 2,027
Finding: No significant difference vs placebo in hot flush frequency (MD 0.07 flushes/day; 95% CI -0.43 to 0.56; p = 0.79); insufficient evidence to support use for menopausal symptoms.
🟢 High quality Academic Effect size: MD 0.07 flushes/day (NS)
View on PubMed
Efficacy of black cohosh-containing preparations on menopausal symptoms: a meta-analysis
PMID: 20085176 2010 統合分析
Finding: Black cohosh improved vasomotor symptoms by 26% vs placebo (95% CI 11%–40%); significant heterogeneity between trials noted.
Effect size: 26% improvement vs placebo (95% CI 11%–40%)
View on PubMed
Menopause: a standardized isopropanolic black cohosh extract (remifemin) is found to be safe and effective for menopausal symptoms
PMID: 22157510 2012 RCT (double-blind) n = 304
Finding: Remifemin confirmed efficacy and tolerability for menopausal symptoms, particularly hot flashes; specific effect sizes not reported in abstract.
⚠️ Industry-funded
View on PubMed
Effect of black cohosh (cimicifuga racemosa) on vasomotor symptoms in postmenopausal women: a randomized clinical trial
PMID: 25276716 2013 RCT (double-blind) n = 84
Finding: Significant reduction in hot flash severity and frequency at weeks 4 and 8 vs placebo (p < 0.05 for both timepoints).
🟠 Limited quality Effect size: p < 0.05 (exact SMD not reported)
View on PubMed
Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1
PMID: 16782922 2006 RCT (double-blind) n = 132
Finding: Black cohosh reduced hot flash score by 20% vs 27% for placebo; no significant difference (p = 0.53); frequency reduction 17% vs 26% for placebo (p = 0.36).
🟢 High quality Government Effect size: MD not significant; placebo numerically superior
View on PubMed
A comparative study on the effect of black cohosh and evening primrose oil on menopausal hot flashes
PMID: 29619387 2018 RCT (open-label) n = 80
Finding: Black cohosh significantly reduced hot flash frequency (p < 0.001) and was superior to evening primrose oil (p < 0.05); no placebo arm — head-to-head comparison only.
🟠 Limited quality Effect size: p < 0.05 vs evening primrose (no placebo arm; no SMD reported)
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
L4b EU EFSA
Cautious
L4c UK NHS
Cautious
black cohosh is believed to balance oestrogen and progestogen levels [but these] may help with some menopause symptoms but this is not supported by scientific evidence. source↗
L4d TW TFDA / 衛福部
Cautious
衛部藥輸字第026341號 醫師藥師藥劑生指示藥品 喜婦寧錠 Cimidona® tablets 喜婦寧錠為一草藥產品,其含有來自Cimicifuga racemosa之根莖部乾燥萃取物Ze 450。【禁忌】:肝功能受損者不得使用。 source↗
L4e WHO
Supportive
WHO Monographs on Selected Medicinal Plants, Volume 2 (Geneva: WHO, 2002, pp. 55–65): Rhizoma Cimicifugae Racemosae — 'Uses supported by clinical data: treatment of climacteric symptoms such as hot flushes, profuse sweating, sleeping disorders and nervous irritability.' source↗
L5a NIH Office of Dietary Supplements
Cautious
L5b Mayo Clinic
Cautious
Many people use black cohosh to ease menopause symptoms. However, studies of how well black cohosh works have had mixed results. It's rare, but there may be a link between black cohosh and liver damage. source↗
L5c Cleveland Clinic
Cautious
L5d Harvard Health
Against
L5e Specialty Society (condition-mapped)
Against
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬7 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-hot-flashes-INT-black-cohosh-001 繁體中文版 →